Inflammation, cell adhesion molecules, and stroke: Tools in pathophysiology and epidemiology?

Stroke

Volumn 33, Issue 9, 2002, Pages 2141-2143

  Blann, Andrew D ^a,c   Ridker, Paul M ^b   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cell adhesion molecules; Inflammation; Risk factors; Stroke, ischemic

Indexed keywords

C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYTOKINE; FIBRINOGEN; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; CELL INTERACTION; CYTOKINE RELEASE; DIABETES MELLITUS; EDITORIAL; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; IMMUNOGLOBULIN GENE; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SMOKING; STROKE; THROMBOCYTE; THROMBOSIS; VARIANT ANGINA PECTORIS;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CEREBROVASCULAR ACCIDENT; COMORBIDITY; FIBRINOGEN; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; PREDICTIVE VALUE OF TESTS; RISK; RISK FACTORS;

EID: 0036713295     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000029008.00497.D3     Document Type: Editorial

References (47)

1. Recombinant soluble P-selectin ligand-1 protects against myocardial ischemic reperfusion in cats
2. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat
3. Administration of monoclonal antibodies against vascular cell adhesion molecule-1/very late antigen-4 abrogates predisposing autoimmune diabetes in NOD mice
4. Differential expression of the cell adhesion molecules ICAM-1, VCAM-1 and E-selectin in normal and post-transplantation myocardium
5. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumours
6. Plasma concentrations of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men
7. Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: Relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events
8. Soluble L-selectin is present in human plasma at high levels and retains functional activity
9. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP 140
10. The origin of P-selectin as a circulating plasma protein
11. Hypothesis: Is soluble P-selectin a new marker of platelet activation?
12. Plasma P-selectin is increased in thrombotic consumptive disorders
13. Elevated circulating P-selectin in insulin dependent diabetes mellitus
14. Increased soluble P-selectin following myocardial infarction: A new marker for the progression of atherosclerosis
15. Soluble P-selectin and the risk of future cardiovascular events
16. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells
17. Soluble E-selectin, ICAM-1, and VCAM-1 in systemic and coronary circulation in patients with variant angina
18. Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease
19. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease
20. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty
21. Increased levels of soluble adhesion molecules in atherosclerosis
22. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
23. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating ICAM-1, E-selectin, P-selectin and thrombomodulin
24. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis
25. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk
26. Cellular adhesion molecules on vascular smooth muscle cells
27. Soluble E-selectin enhances intercellular adhesion molecule-1 (ICAM-1) expression in human tumour cell lines
28. Tumour necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells
29. Circulating cell adhesion molecules and death in patients with coronary artery disease
30. Soluble adhesion molecules and prediction of coronary heart disease: A prospective study and meta-analysis
31. A longitudinal prospective study of soluble adhesion molecules in acute stroke
32. Soluble adhesion molecules reflect endothelial cell activation in ischaemic stroke and in carotid atherosclerosis
33. Circulating selectin and immunoglobulin type adhesion molecules in acute ischaemic stroke
34. E selectin, intercellular adhesion molecules-1, vascular adhesion molecule-1 and von Willebrand factor following stroke
35. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis
36. Soluble intercellular adhesion molecule-1 and risk of future ischaemic stroke: A nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort
37. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
38. Influence of smoking on soluble adhesion molecules and endothelial cell markers
39. Increased levels of soluble adhesion molecules in type (non-insulin) diabetes mellitus are independent of glycaemic control
40. Effects of changes in smoking and other characteristics on clotting and the risk of ischaemic heart disease
41. Inflammation and thrombosis: The clot thickens
42. Raised C-reactive protein levels in serum from smokers
43. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
44. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
45. Plasma concentration of C-reactive protein and risk of ischaemic stroke and transient ischaemic attack: The Framingham study
46. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a) and standard cholesterol screening as predictors of peripheral arterial disease
47. Evaluation of nine automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications, part 2